RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Histamine for Itch

Atopic dermatitis (AD) is as chronic, inflammatory skin disorder affecting 20% of the world's population. Intense itch and skin pain are the main symptoms.

Official registry: https://clinicaltrials.gov/study/NCT06503510 · Aalborg University · enrollment listed as 20

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Histamine, Cowhage, or bovine adrenal medulla (BAM8-22). The registry lists allocation as na. Atopic dermatitis (AD) is as chronic, inflammatory skin disorder affecting 20% of the world's population.

They plan to enroll about 20 people at 3 sites. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

The Role of the Interleukin-13 Pathways on Pain and Itch Sensitivity in Patients With Atopic Dermatitis and Healthy Volunteers

Interventions: Histamine, Cowhage, bovine adrenal medulla (BAM8-22)

Primary outcome (registry wording): Measuring itch by computerized Visual Analog Scale Scoring

Who it is for (from inclusion criteria)

Ages 18 Years to 60 Years
Healthy men and women

Who the registry excludes

Pregnancy or lactation
Drug addiction defined as any use of cannabis, opioids, or other drugs
Moles, wounds, scars, or tattoos in the area to be treated or tested
Current use of medications that may affect the trial such as antihistamines and pain killers (use of antihistamines should be discontinued 72 hours before the experiment and all topical agents and emollients should be discontinued 24 hours before the experiment)
Use of systemic and topical corticosteroids
Consumption of alcohol or painkillers 24 hours before the study days and between these
Acute or chronic pain

Public study contact (from the registry)

Silvia Lo Vecchio

21397785

slv@hst.aau.dk

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

3 listed

Aalborg University — Gistrup, Aalborg, Denmark (recruiting)
CNAP — Gistrup, Aalborg, Denmark (active_not_recruiting)
Aalborg University — Aalborg, Denmark, Denmark (not_yet_recruiting)

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phasePittsburgh, Pennsylvania

Not a traditional drug phase: Blood draw, skin biopsy or urine collection for Cutaneous T-cell Lymphoma

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

NCT00177268 · Official ClinicalTrials.gov record · University of Pittsburgh

RecruitingNot a traditional drug phaseBethesda, Maryland

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

This study will examine microbes (e.g., bacteria, fungi, viruses) that live on human skin and how microbes contribute to health and disease. It will analyze healthy human skin and how the these microorganisms might change in patients with atopic dermatitis (AD), a skin condition also known as eczema.

NCT00605878 · Official ClinicalTrials.gov record · National Human Genome Research Institute (NHGRI)

RecruitingPhase 2Bethesda, Maryland

Phase 2: testing Trimethoprim/sulfamethoxazole (TMP/SMZ) for Eczema

Background: \- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S.

NCT01631617 · Official ClinicalTrials.gov record · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

FAQ about this NCT record

Is NCT06503510 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT06503510?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT06503510?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary